Cost-effectiveness of health care interventions to address intimate partner violence: What do we know and what else should we look for?

Violence Against Women

Volumn 17, Issue 3, 2011, Pages 389-403

  Gold, Lisa ^a   Norman, Richard ^b   Devine, Angela ^c   Feder, Gene ^d   Taft, Angela J ^e   Hegarty, Kelsey L ^f  

^a DEAKIN UNIVERSITY   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e LA TROBE UNIVERSITY   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

cost effectiveness; domestic violence; evaluation

Indexed keywords

AUSTRALIA; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; MALE; PARTNER VIOLENCE; UNITED KINGDOM;

AUSTRALIA; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; FEMALE; HEALTH POLICY; HUMANS; INTIMATE PARTNER VIOLENCE; MALE; UNITED KINGDOM;

EID: 79954500842     PISSN: 10778012     EISSN: 15528448     Source Type: Journal    
DOI: 10.1177/1077801211398639     Document Type: Review

References (38)

1. Begg, S., Vos, T., Barker, B., Stevenson, C., Stanley, L., & Lopez A.D. (2007). The burden of disease and injury in Australia 2003. PHE 82. Canberra: Australian Institute of Health and Welfare.
2. Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21, 271-292.
3. Browne-Miller, A. (n.d.). Making the case for domestic violence prevention through the lens of cost-benefit: A manual for domestic violence practitioners (and the state and local policy-makers they present to). San Raphael, CA: Transforming Communities Technical Assistance, Training and Resource Centre. Retrieved fromhttp://www.transformcommunities.org/cdvp/CDVP_toc.html.
4. Chanley, S.A., Chanley, J.J., & Campbell, H.E. (2001). Providing refuge: The value of domestic violence shelter services. American Review of Public Administration, 31, 393-413.
5. Clark, K.A., Biddle, A.K., & Martin, S.L. (2002). A cost-benefit analysis of the Violence Against Women Act of 1994. Violence Against Women, 8, 417-428.
6. Cohen, M.A., Miller, T.R., & Rossman, S.B. (1994). The costs and consequences of violent behavior in the United States. In J. Roth & A. Reiss (Eds.), Understanding and preventing violence (Vol. 4, pp. 67-166). Washington, DC: National Academy Press.
7. Commonwealth of Australia. (2009). The cost of violence against women and their children. Canberra, Australia: Department of Families, Housing, Community Services and Indigenous Affairs (FaHCSIA).
8. Corso, P. (2009). Economic analysis and the prevention of intimate partner violence. In C. Mitchell & D. Anglin (Eds.), Intimate partner violence: A health-based perspective (pp. 53-60). New York: Oxford University Press.
9. Dolan, P., Gudex, C., Kind, P., & Williams, A. (1996). The time trade-off mehod: Results from a general population study. Health Economics, 5, 141-154.
10. Domino, M.E., Morrissey, J.P., Chung, S., Huntington, N., Larsen, M.J., & Russell, L.A. (2005). Service use and costs for women with co-occurring mental and substance use disorders and a history of violence. Psychiatric Services, 56, 1223-1232.
11. Donaldson, C. (1999). Valuing the benefits of publicly-provided health care: Does "ability to pay" preclude the use of "willingness to pay." Social Science and Medicine, 49, 551-563.
12. Drummond, M., Barbieri, M., Cook, J., Glick, H.A., Lis, J., & Malik F.,et al.(2009). Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value in Health, 12, 409-418.
13. Drummond, M., Brown, R., Fendrick, A.M., Fullerton, P., Neumann, P., Taylor, R., & Barbieri, M. (2003). Use of pharmacoeconomics information - report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making. Value in Health, 6, 407-16.
14. Drummond, M.F., Sculpher, M.J., Torrance, G.W., O'Brien, B.J., & Stoddart, G.L. (2005). Methods for the economic evaluation of health care programmes (3rd ed.). Oxford, UK: Oxford University Press.
15. Feder, G., Ramsay, J., Dunne, D., Rose, M., Arsene, C., & Norman, R.,et al.(2009). How far does screening women for domestic (partner) violence in different health-care settings meet criteria for a screening programme? Systematic reviews of nine UK national screening committee criteria. Health Technology Assessment, 13, 1-136.
16. Gregory, A., Ramsay, J., Agnew-Davies, R., Baird, K., Devine, A., & Dunne, D.,et al.(2010). Primary care Identification and Referral to Improve Safety of women experiencing domestic violence (IRIS): Protocol for a pragmatic cluster randomised controlled trial. BMC Public Health, 10, 1471-2458.
17. Hawthorne, G., Richardson, J., & Osborne, R. (1999). The Assessment of Quality of Life (AQoL) instrument: A psychometric measure of health-related qualitty of life. Quality of Life Research, 8, 209-224.
18. Hegarty, K., Bush, R., & Sheehan, M. (2005). The Composite Abuse Scale: Further development and assessment of reliability and validity of a multidimensional partner abuse measure in clinical settings. Violence and Victims, 20, 529-547.
19. Hegarty, K.L., Gunn, J.M., O'Doherty, L., Taft, A.T., Chondros, P., & Feder, G.,et al.(2010). Women's evaluation of abuse and violence care in general practice: A cluster randomised controlled trial (weave). BMC Public Health, 10, 2. Retrieved fromhttp://www.biomedcentral.com/1471-2458/10/2.
20. Horsman, J., Furlong, W., Feeny, D., & Torrance, G. (2003). The Health Utilities Index (HUI): Concepts, measurement properties and applications. Health and Quality of Life Outcomes, 1, 54. Retrieved fromhttp://www.hqlo.com/content/1/1/54.
21. Kassirer, J.P., & Angell, M. (1994). The journal's policy on cost-effectiveness analyses [editorial]. New England Journal of Medicine, 331, 669-670.
22. Kuntz, K.M., & Weinstein, M. (2001). Modeling in economic evaluation. In M. Drummond & A. McGuire (Eds.), Economic evaluation in health care: Merging theory with practice (pp. 141-171). Oxford, UK: Oxford University Press.
23. Norman, R., Spencer, A., Eldridge, S., & Feder, G. (2010). Cost-effectiveness of a programme to detect and provide better care for female victims of intimate partner violence. Journal of Health Services Research and Policy, 15, 143-149.
24. Oakley, A. (1989). Who's afraid of the randomized controlled trial? Some dilemmas of the scientific method and "good" research practice. Women and Health, 15, 25-59.
25. O'Brien, B. (1996). Economic evaluation of pharmaceuticals: Frankenstein's monster or vampire of trials? Medical Care, 34, DS99-DS108.
26. Petrou, S., & McIntosh, E. (2009). Women's preferences for attributes of first-trimester miscarriage management: A stated preference discrete choice experiment. Value in Health, 12, 551-559.
27. Philips, Z., Bojke, L., Sculpher, M., Claxton, K., & Golder, S. (2006). Good practice guidelines for decision-analytic modelling in health technology assessment. Pharmacoeconomics, 24, 355-371.
28. Ramsay, J., Carter, Y.H., Davidson, L., Dunne, D., Eldridge, S., & Hegarty, K.,et al.(2009). Advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well-being of women who experience intimate partner abuse. Cochrane Database of Systematic Reviews, 3, CD005043. doi:10.1002/14651858.CD005043.pub2.
29. Ryan, M. (2000). Using conjoint analysis to elicit preferences for health care. British Medical Journal, 320, 1530-1533.
30. Shiell, A., Donaldson, C., Mitton, C., & Currie, G. (2002). Glossary: Health economic evaluation. Journal of Epidemiology and Community Health, 56, 85-88.
31. Shiroiwa, T., Sung, Y.-K., Fukuda, T., Lang, H.-C., Bae, S.-C., & Tsutani, K. (2010). International survey on willingness-to-pay (WTP) for one additional QALY gained: What is the threshold of cost effectiveness? Health Economics, 19, 422-437.
32. Snow Jones, A. (Ed.). (2007, June). Health care costs of intimate partner violence. Family Violence Prevention and Health Practice, 1(5). Retrieved fromhttp://endabuse.org/health/ejournal/archive/1-5/.
33. Sonnenberg, F.A., & Beck, J.R. (1993). Markov models in medical decision making: A practical guide. Medical Decision Making, 13, 322-338.
34. Taft, A.J., Small, R., Hegarty, K., Lumley, J., Watson, L.F., & Gold, L. (2009). MOSAIC (MOtherS' Advocates In the Community): Protocol and sample description of a cluster randomised trial of mentor mother support to reduce intimate partner violence among pregnant or recent mothers. BMC Public Health, 9, 159. Retrieved fromhttp://www.biomedcentral.com/1471-2458/9/159.
35. Taylor, S.J., & Armour, C.L. (2000). Measurement of consumer preference for treatments used to induce labour: A willingness to pay approach. Health Expectations, 3, 203-216.
36. Walby, S. (2009). The cost of domestic violence: Update 2009. Lancaster, UK: Lancaster University. Retrieved fromhttp://www.lancs.ac.uk/fass/doc_library/sociology/Cost_of_domestic_violence_update.doc%20.
37. Wathen, N.C., & MacMillan, H.L. (2003). Interventions for violence against women: Scientific review. Journal of the American Medical Association, 289, 589-600.
38. Wittenberg, E., Lichter, E.L., Ganz, M.L., & McCloskey, L.A. (2006). Community preferences for health states associated with intimate partner violence. Medical Care, 44, 738-774.